Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.01% atropine for prevention and control of preclinical myopia in children
ChiCTR2200055482Phase 4Recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Jan 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atropine in myopia and pre-myopia (2 arms), sponsored by Tianjin Medical University Eye Hospital. Primary endpoints: Axial length and Refractive error. Started Jan 2022; status: recruiting.
02
Drugs
atropine
03
Conditions
myopiapre-myopia
Beyond the preview
Go deeper on ChiCTR2200055482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055482.